Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

BIOJAM SA

NIF 513642749
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €565,725 34 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €565,725 34 contracts
A2 · Late Publication €2,789,218,586 936 contracts
Contract published to BASE more than 10 days after the signing date
LOW €2,789,218,586 936 contracts
A5 · Threshold Splitting €2,045,718 41 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €2,045,718 41 contracts
A6 · Low Competition €148,582 6 contracts
Only one bidder participated in a competitive procedure
MEDIUM €148,582 6 contracts
A9 · Abnormal Price Reduction €3,075,626,296 564 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €3,075,626,296 564 contracts
C3 · Missing Mandatory Fields €596,165 46 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €596,165 46 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

66
€426,727,149
155
€417,529,286
45
€397,058,531
9
€344,149,881
26
€99,258,113
38
€84,193,004
20
€82,439,405
19
€81,438,653
40
€81,324,066
26
€78,202,474
13
€70,753,547
46
€67,665,820
107
€64,473,806
50
€64,199,841
62
€63,746,789
55
€62,099,635
37
€52,602,632
15
€44,752,013
12
€44,422,466
33
€43,470,809
Page 1 of 3 · 57 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 6 contracts

Aquisição de Medicamentos Exclusivos Biojam, S.A. para o ano de 2025
PT · 11257819 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€5,546 2025-01-27
Ajuste direto para aquisição de F481 - Fulvestrant [250 mg/ 5 ml; sol. inj.; seringa] e M55 - Meropenem [1g; iv; f/amp].
PT · 10964993 · Ajuste Direto Regime G...
A6 · Low Competition
€14,839 2024-10-11
AE/892/2024 Medicamentos Exclusivos Biojam
PT · 10642848 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€92,171 2024-03-08
AUE BUSSULFANO
PT · 10994973 · Consulta Prévia
A2 · Late Publication A6 · Low Competition
€200 2024-02-28
MEDICAMENTOS ÚNICOS BIOJAM
PT · 10808877 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€2,226 2024-01-31
MEROPENEM 1000 MG PÓ SOL INJ FR IV
PT · 10506148 · Ajuste Direto Regime G...
A6 · Low Competition
€33,600 2024-01-23
Overview
Total Value Won
€3,086,484,104
Contracts Won
1,271
Score 47255 · CRITICAL RISK
NIF
513642749
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • L.A. [P-61fc]
    Administrador
    since 2015-08-18
  • A.J. [P-b35d]
    Fiscal Único
    since 2015-08-18
  • A.A. [P-f9f9]
    Fiscal Único
    since 2016-02-18
  • A.A. [P-f9f9]
    Fiscal Único
    since 2020-12-28
  • J.M. [P-51db]
    Fiscal Único
    since 2024-11-20
  • R.M. [P-1049]
    Fiscal Único
    since 2024-11-20
  • V.M. [P-aa58]
    Fiscal Único
    since 2020-12-28
  • S.P. [P-b833]
    Fiscal Único
    2015-08-18 → 2016-02-18
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned